BELLEVILLE – A dialysis patient claims defective and dangerous products were used in the course of his treatment.
Anthony Floyd filed the suit March 16 in St. Clair County Circuit Court against Fresenius Medical Care North America Inc., Fresenius USA Inc., Fresenius Medical Care Holdings, Fresenius USA Manufacturing Inc., Fresenius USA Marketing Inc., and Fresenius USA Sales Inc.
According to the complaint, the plaintiff received dialysis treatment in 2011 and alleges he suffered serious injury that was partially caused by the defendants' products. Those products, labeled “GranuFlo” or “NaturaLyte,” are used in a solution for dialysis.
The suit alleges that administering GranuFlo to a patient results in elevated blood levels of bicarbonate. The most serious result can be sudden cardiac death.
The dangers of elevated bicarbonate levels in the blood were known in the medical community as early as 2004 and internally by the defendants in April 2002, the suit states.
Still, in 2011 and despite FDA recalls, the plaintiff claims he was given GranuFlo during dialysis and suffered a sudden cardiac event, the complaint alleges.
Floyd alleges eight counts against the defendants, including breach of warranty, negligence and strict liability.
For each count, the plaintiff seeks an amount sufficient to fully and fairly compensate him for his injuries and damages, court costs, interest and all other relief the court deems appropriate. He also demands a trial by jury.
He is represented by John J. Driscoll of The Driscoll Firm PC in St. Louis.
St. Clair County Circuit Court case number 16-L-150